Healthcare entity
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention Roche Pharma, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3 across the same-window beat baseline.
Last mentioned: Mar 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. Of the tracked stories, 1 of 1 also mention Roche Pharma, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.9 in the same window. We currently track 1 Healthcare story that mention NIPER Raebareli, all published on March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NIPER Raebareli. Shared-story counts are live from our verified record — not editorial picks.
Roche Pharma and NIPER Raebareli have signed a Memorandum of Understanding to enhance pharmaceutical education and research capability building in India. This collaboration focuses on bridging the gap between academic research and industry requirements to foster innovation in the domestic healthcare sector.
Source: bangladeshsun.com · news.webindia123.com
NIPER Raebareli is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
